Ledger.Open graph →
SEC Form D · filed November 15, 2013

CATABASIS PHARMACEUTICALS INC

Offering
$32.4M
Sold
$32.4M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Rick P. Smith · Venice, CAExec · DirectorMike Schneider · Durham, NCDirectorMichael Jirousek · Cambridge, MAExecJeff Alexander · Colorado Springs, CODirectorDavid Juliano · Sunnyvale, CADirectorRon Bernal · Sunnyvale, CADirectorS Squared Capital, LLC · New York, NYExec · DirectorS Squared Technology, LLC · New York, NYDirectorH. Brian Thompson · McLean, VAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗